Horizon Technology Finance Third Quarter 2026 Earnings Call - HORIZON TECHNOLOGY FINANCE CORP

Financial Performance:

• Reported Net Investment Income (NII) of $0.19 per share for Q3 2026, covering declared monthly distributions of $0.06 per share (Jan–Mar 2027).
• Net Asset Value (NAV) declined to $5.56 per share (down $0.67 quarter-over-quarter), primarily driven by write-downs on stressed investments.
• Debt investment portfolio grew to $650 million for the fourth consecutive quarter, with a debt portfolio yield of 14.7% (industry-leading) and onboarding yields of 12.6%.
• Reported investment income of $24.1 million, down from $26.3 million in Q3 2025, due to lower interest income.
• Total expenses were $12.5 million; net expenses were $11.5 million after a $1 million advisor fee waiver.
• Interest expense remained flat at $7.8 million year-over-year.
• Debt-to-equity ratio was 1.12x, with net leverage (net of cash) at 0.82x, well below target levels.
• Available liquidity totaled $211 million ($108M cash + $103M borrowing capacity).

Guidance and Future Outlook:

• Management targets delivering NII at or above declared distributions over the long term.
• Anticipates lower prepayment activity in Q4 2026 compared to the elevated levels seen in Q3.
• Expects the IPO market to remain muted for the remainder of 2026, with potential exceptions for major AI valuations.
• Aims to materially grow the portfolio in Q4 and beyond, leveraging a backlog of $351 million.
• Management expects NAV improvements to become more apparent as credit challenges are addressed moving into 2027.
• Pipeline activity is projected to convert over a rolling six-month basis.

Business Segments and Product Lines:

• Funded nine new debt investments totaling $98 million in Q3 within target sectors (Life Sciences, Tech, AI).
• Recorded $81 million in loan prepayments and partial paydowns, providing capital for redeployment.
• Portfolio now includes equity/warrants in 95 companies, with a fair value of $29 million; realized $2 million in proceeds from warrant/redemption investments in the quarter.
• Under the new 1-to-5 credit scale, 88% of debt portfolio fair value is rated 1–3, while 12% is rated 4–5.
• Appointed Manuel Enriquez as the new Chief Growth and Strategy Officer to accelerate origination and leverage past experience.
• 98% of the portfolio bears floating rates, positioning it to benefit from further rate increases.

Market and Competitive Landscape:

• Venture capital investment volume rose 44% year-over-year through Q3 2026, though heavily concentrated in large AI deals.
• Market described as "bifurcated," with top-tier AI companies receiving disproportionate capital while non-AI exit activity remains muted.
• Competitive positioning remains strong, with portfolio yields at or near the top of the BDC industry.
• Strategic alignment with Monroe Capital continues to facilitate co-investments and expand the deal funnel.

Risks and Challenges:

• NAV stress caused by write-downs on specific stressed credits; management notes the convergence of these issues was "shocking."
• Uncertainty regarding turnaround timelines for distressed assets; most affected credits are currently non-accrual.
• Exit market remains quiet for non-AI companies due to macro and geopolitical uncertainties.
• Potential for slower prepayment activity in Q4 compared to Q3 levels.

Management Commentary and Tone:

• Tone was confident regarding pipeline strength and originations but cautious regarding the timeline for NAV recovery.
• CEO Mike Balkin emphasized the "scalable platform" and "relentless work" of teams, asserting the company is "in an excellent position" despite current NAV headwinds.
• CFO Dan Trollio and CIO Paul Seitz highlighted the strength of the balance sheet and the effectiveness of the floating rate structure.
• Management expressed optimism that strategic initiatives and the Enriquez appointment will drive sustainable growth.

Analyst Questions and Answers:

• Q (Melissa Waddell, UBS): Asked for timelines on stabilizing stressed credits and prepayment normalization. A: Seitz declined specific timelines due to sensitivity but confirmed "all hands on deck" efforts; prepayments expected to normalize in Q4, with portfolio growth of ~$30M+ anticipated.
• Q (Paul Johnson, KBW): Inquired if stressed credits are non-accrual and clarified the discrepancy between $98M originations and $89M funding in reports. A: Confirmed distressed assets are primarily in the non-accrual bucket; clarified the $10M variance is due to funding location within the joint venture.
• Q: Asked about the strategic value of the new Chief Growth Officer role. A: Management highlighted Enriquez's Hercules background and immediate impact on origination efforts and relationships.

Other Key Points:

• Repurchased over 2 million shares at an average price of $4.90 during the quarter.
• Undistributed spillover income stood at $0.24 per share as of September 30.
• 100% of outstanding debt principal bears interest at floating rates, with 98% set to benefit from further index increases.
• Board declared distributions for Q1 2027 ($0.06/month) based on current outlook and spillover income.